Biomaterials Executive, Arthur J. Coury, PhD, Joins InVivo Therapeutics Corporation (NVIV)' Business Advisory Board  
9/11/2012 10:04:50 AM

BRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma conditions, today announced that Arthur J. Coury, PhD, has joined the company as an advisor to the CEO.